SANUWAVE Health Inc. (SNWV.OB) Announces European Launch of orthoPACE™ Shock Wave Technology
SANUWAVE Health Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced the European launch of its orthoPACE™ device for orthopedic, trauma and sports medicine indications. The orthoPACE integrates SANUWAVE’s proprietary Pulsed Acoustic Cellular Expression (PACE™) extracorporeal shock wave technology (ESWT) used to treat a variety of chronic and acute conditions in hard and soft tissue. Christopher M. Cashman, president and CEO of SANUWAVE, said orthoPACE has received positive feedback from healthcare professionals and distributors in the European market, and that the company anticipates further…